Russian mRNA cancer 'vaccine' shows promise in pre-clinical trials, part of growing immunotherapy trend in cancer treatment.

While many people are aware of the link between HIV and Tuberculosis (TB), fewer know about another common co-infection: Human Papillomavirus (HPV ... Although the mechanism of this relationship is ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

HPV is responsible for more than 95% of cervical cancer cases in South Africa. If a high-risk HPV infection persists, it can ...

As one of the leading causes of death worldwide, cancer and its many types have cut many lives short -- some of whom were ...

Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...

Kate O'Brien, Director of the Department of Immunization, Vaccines and Biologicals at WHO Safeguarding children and ...

Press Release - At the handing over ceremony for the project held at the Government House in Dutse, Governor Umar Namadi commended the interventions saying that the programme has contributed to the ...

Comparing plans with similar characteristics, such as size, geographic location, or demographics served, allows for more meaningful insights and improvement opportunities.

Researchers have identified the molecular and cellular mechanisms that transform healthy ... Around 30% of oral cancer cases are caused by human papillomavirus (HPV). By activating a signaling ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.